Herbert Irving Comprehensive Cancer Center [clinicaltrials_resource:395568fd2a1502c229d831737f991b5e]
John Chabot, MD [clinicaltrials_resource:0432e6366240093e34f2ec094b15154e]Linda T. Vahdat, MD [clinicaltrials_resource:11f4b50948aedb273b5549d269ce6600]Howard L. Kaufman, MD [clinicaltrials_resource:12bb8b767db92c95ad8f0546669343de]Abraham Kroon, MD, PhD [clinicaltrials_resource:1526800ff7e961797416facd992a3b32]David R. Bickers, MD [clinicaltrials_resource:15ffc91e18011f874f4b0ff77133a577]Mitchell S. Cairo, MD [clinicaltrials_resource:1a35f4da0f9cc43cc129337156ea2315]Ajai Chari, MD [clinicaltrials_resource:2213de2b51bb04dd3c576e383464d032]Charles S. Hesdorffer [clinicaltrials_resource:237d8e1212d7583f82afcbea4cfb8c58]Ronald D. Ennis, MD [clinicaltrials_resource:246ced4d2d9741510e55dcce51aad014]Alfred I. Neugut, MD, PhD [clinicaltrials_resource:2e54ac726d0ec37225f237baee3114e2]Gwen L. Nichols, MD [clinicaltrials_resource:3243ed068df3e900b6e1b670ace9181f]Julia L. Glade-Bender, MD [clinicaltrials_resource:393c5e0794baaedb86c375eac79bc2ef]Dawn Hershman, MD [clinicaltrials_resource:4ccdc01de5ba16ab58860f32de2ecda4]Charles S. Hesdorffer, MD [clinicaltrials_resource:5afedd2b8259dde9d9e5992c421d0c41]Kyriakos P. Papadopoulos, MD [clinicaltrials_resource:627d95a68272989c846c2cfdfe91a86e]Casilda Balmaceda, MD [clinicaltrials_resource:62f26ef67bc165398a53b76c2f5a66d3]Adolfo A. Ferrando, MD, PhD [clinicaltrials_resource:6aa66e201982195efb8c5c49a7c78e58]Amy D. Tiersten, MD [clinicaltrials_resource:70f942289e3e750e10007880fa575009]Robert N. Taub, MD, PhD [clinicaltrials_resource:8913e19b975fec65bb43e5fd1f1de4f9]Dawn Hershman, MD [clinicaltrials_resource:8cd8221e0b13ae0757bb1a8f6506f782]Haralambos Raftopoulos, MD [clinicaltrials_resource:9ff67c12e5d4da1ec5fb4168356a1c36]Heather Greenlee, PhD, ND [clinicaltrials_resource:a435d6237a352c4c22b3b9cef3b0395d]Dawn Hershman, MD [clinicaltrials_resource:a70606b447462a97fa2eb67fea273789]Dawn Hershman, MD [clinicaltrials_resource:a956778b559338f0b210b5c6484d520f]Adolfo A. Ferrando, MD, PhD [clinicaltrials_resource:a99675fe7d26beb5be5c9d5835aae7ce]Gwen L. Nichols, MD [clinicaltrials_resource:a9f98966d33cf5b5357095f7b4763219]David G. Savage, MD [clinicaltrials_resource:b4477e84fe6b2a8a989ba582244b4a08]Dawn Hershman, MD [clinicaltrials_resource:b7e08eaa7691b1aef0e1f66db8c01309]Dawn Hershman, MD [clinicaltrials_resource:c6beff2eaae7f73502eb3bb316eb515c]Ajai Chari, MD [clinicaltrials_resource:cbeca0b932b61351a4dceaab25aee597]David G. Savage, MD [clinicaltrials_resource:cd10c47d32ee14547a58b3e547cb53c8]Daniel P. Petrylak, MD [clinicaltrials_resource:d1173273e8b2ddf5b9ff435049c06725]Kara Kelly, MD [clinicaltrials_resource:f6177ca1d02220bec5100dc38da4abf6]Thomas J. Herzog, MD [clinicaltrials_resource:f698d384e67f916a56201053611829ad]
affiliation [clinicaltrials_vocabulary:affiliation]
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Persistent Epithelial Ovarian Cancer, Fallopian Tube, or Primary Peritoneal Cancer [clinicaltrials:NCT00003064]Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer [clinicaltrials:NCT00003124]High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Lung Cancer [clinicaltrials:NCT00003284]Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer [clinicaltrials:NCT00007982]Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients Who Have Multiple Myeloma or Primary Systemic Amyloidosis [clinicaltrials:NCT00007995]Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma [clinicaltrials:NCT00008008]Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia [clinicaltrials:NCT00008164]Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Acute Leukemia [clinicaltrials:NCT00008190]Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast Cancer [clinicaltrials:NCT00008203]Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic Disorders [clinicaltrials:NCT00008307]Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Chemotherapy Alone in Treating Women With Stage IV Breast Cancer [clinicaltrials:NCT00012311]CP4071 in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma [clinicaltrials:NCT00017446]Vaccine Therapy in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00022568]Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer [clinicaltrials:NCT00024271]Interferon Alfa and Thalidomide in Treating Patients With Soft Tissue Sarcoma or Bone Sarcoma [clinicaltrials:NCT00026416]Vaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal Cancer [clinicaltrials:NCT00027833]Temozolomide and Thalidomide in Treating Patients With Metastatic, Locally Advanced, or Unresectable Leiomyosarcoma [clinicaltrials:NCT00033709]Vaccine Therapy With or Without Sargramostim in Treating Patients With High-Risk or Metastatic Melanoma [clinicaltrials:NCT00037037]Zoledronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy After Surgery For Early Stage Breast Cancer [clinicaltrials:NCT00049452]Silymarin (Milk Thistle Extract) in Treating Patients With Acute Lymphoblastic Leukemia Who Are Receiving Chemotherapy [clinicaltrials:NCT00055718]G-CSF in Stimulating Peripheral Stem Cells for Autologous Stem Cell Transplant in Treating Patients With Chronic Phase Chronic Myeloid Leukemia in Complete Remission [clinicaltrials:NCT00233961]Doxorubicin Hydrochloride Liposome, Melphalan, and Bortezomib in Treating Patients With Relapsed or Refractory Stage I, Stage II, or Stage III Multiple Myeloma [clinicaltrials:NCT00334932]Collecting Stem Cells in Patients With Waldenstrom's Macroglobulinemia [clinicaltrials:NCT00899119]
collaborator [clinicaltrials_vocabulary:collaborator]
Docetaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer [clinicaltrials:NCT00002775]Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Persistent Epithelial Ovarian Cancer, Fallopian Tube, or Primary Peritoneal Cancer [clinicaltrials:NCT00003064]Topotecan and Paclitaxel in Treating Patients With Recurrent or Metastatic Cancer of the Cervix [clinicaltrials:NCT00003065]Docetaxel Combined With Estramustine in Treating Women With Metastatic Breast Cancer [clinicaltrials:NCT00003066]Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer [clinicaltrials:NCT00003124]High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Lung Cancer [clinicaltrials:NCT00003284]Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [clinicaltrials:NCT00003560]Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer [clinicaltrials:NCT00003633]Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma [clinicaltrials:NCT00003718]Irinotecan in Treating Patients With Stage IV or Recurrent Soft Tissue Sarcoma [clinicaltrials:NCT00003719]Gemcitabine Plus Carboplatin or Cisplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer [clinicaltrials:NCT00004201]Temozolomide in Treating Patients With Recurrent or Progressive Malignant Glioma [clinicaltrials:NCT00004204]Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer [clinicaltrials:NCT00007982]Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients Who Have Multiple Myeloma or Primary Systemic Amyloidosis [clinicaltrials:NCT00007995]Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma [clinicaltrials:NCT00008008]Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia [clinicaltrials:NCT00008164]Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Acute Leukemia [clinicaltrials:NCT00008190]Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast Cancer [clinicaltrials:NCT00008203]Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic Disorders [clinicaltrials:NCT00008307]Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Chemotherapy Alone in Treating Women With Stage IV Breast Cancer [clinicaltrials:NCT00012311]CP4071 in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma [clinicaltrials:NCT00017446]Study of High-Dose Melphalan and Autologous Stem Cell Transplantation in Patients With Primary Light Chain Amyloidosis [clinicaltrials:NCT00017680]Vaccine Therapy in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00022568]Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer [clinicaltrials:NCT00024271]Interferon Alfa and Thalidomide in Treating Patients With Soft Tissue Sarcoma or Bone Sarcoma [clinicaltrials:NCT00026416]Vaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal Cancer [clinicaltrials:NCT00027833]Temozolomide and Thalidomide in Treating Patients With Metastatic, Locally Advanced, or Unresectable Leiomyosarcoma [clinicaltrials:NCT00033709]Vaccine Therapy With or Without Sargramostim in Treating Patients With High-Risk or Metastatic Melanoma [clinicaltrials:NCT00037037]Zoledronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy After Surgery For Early Stage Breast Cancer [clinicaltrials:NCT00049452]Silymarin (Milk Thistle Extract) in Treating Patients With Acute Lymphoblastic Leukemia Who Are Receiving Chemotherapy [clinicaltrials:NCT00055718]G-CSF in Stimulating Peripheral Stem Cells for Autologous Stem Cell Transplant in Treating Patients With Chronic Phase Chronic Myeloid Leukemia in Complete Remission [clinicaltrials:NCT00233961]Doxorubicin Hydrochloride Liposome, Melphalan, and Bortezomib in Treating Patients With Relapsed or Refractory Stage I, Stage II, or Stage III Multiple Myeloma [clinicaltrials:NCT00334932]Collecting Stem Cells in Patients With Waldenstrom's Macroglobulinemia [clinicaltrials:NCT00899119]
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
Herbert Irving Comprehensive Cancer Center [clinicaltrials_resource:395568fd2a1502c229d831737f991b5e]
Bio2RDF identifier
395568fd2a1502c229d831737f991b5e
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:395568fd2a1502c229d831737f991b5e
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:395568fd2a1502c229d831737f991b5e
title
Herbert Irving Comprehensive Cancer Center
@en
type
label
Herbert Irving Comprehensive C ...... 568fd2a1502c229d831737f991b5e]
@en